Nonexudative age-related macular degeneration, bilateral, stage unspecified is a common eye condition that primarily affects older adults. It is a chronic and progressive disease that affects the macula, which is the central part of the retina responsible for clear and sharp vision. The disease occurs when the macula deteriorates, leading to vision loss.
Macular degeneration is divided into two types; exudative and nonexudative. Nonexudative macular degeneration is characterized by the formation of small yellow deposits called drusen under the macula. In the early stages of the disease, there may be no symptoms. However, as the disease progresses, patients may experience blurred or distorted vision, difficulty seeing in low light, and difficulty recognizing faces.
Nonexudative age-related macular degeneration, bilateral, stage unspecified affects both eyes, and the degree of vision loss can vary from person to person. The disease is more common in people over the age of 50 and is a leading cause of vision loss in older adults.
The exact cause of nonexudative age-related macular degeneration, bilateral, stage unspecified is unknown. However, several factors are known to increase the risk of developing the disease. These include:
Nonexudative age-related macular degeneration, bilateral, stage unspecified is diagnosed through a comprehensive eye exam that includes:
Nonexudative age-related macular degeneration (AMD) is a common eye disorder, particularly in people aged over 50 years. It is a degenerative condition that affects the macula, which is the central part of the retina responsible for sharp vision. In this article, we will discuss the treatment options for Nonexudative age-related macular degeneration, bilateral, stage unspecified.
To see full information about treatment please Sign up or Log in